Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Gerontology
|
January 7, 1999
Clinical profile of donepezil in the treatment of Alzheimer's disease
R S Doody
Brain and Language
|
April 1, 1993
A reappraisal of localization theory with reference to aphasia. Part 2: Language theories from outside neurology
R S Doody
The Journal of Nutrition, Health & Aging
|
March 23, 2010
Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design
R S Doody
Brain and Language
|
April 1, 1993
A reappraisal of localization theory with reference to aphasia. Part 1: Historical considerations
R S Doody
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 20, 1999
Clinical benefits of a new piperidine-class AChE inhibitor
R S Doody
Brain and Cognition
|
March 31, 2000
The issue of representation in brain research
R S Doody
The Journal of Prevention of Alzheimer'S Disease
|
December 21, 2017
Is Alzheimer's Disease Drug Development Broken? What Must Be Improved?
R S Doody
JAMA
|
November 14, 2000
Mortality from pneumonia and hip fractures in patients with advanced dementia
R S Doody
Alzheimer Disease and Associated Disorders
|
January 6, 2000
Therapeutic standards in Alzheimer disease
R S Doody
The Journal of Prevention of Alzheimer'S Disease
|
June 25, 2023
Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?
R S Doody, S Skerjanec
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Gerontology
|
January 7, 1999
Clinical profile of donepezil in the treatment of Alzheimer's disease
R S Doody
Brain and Language
|
April 1, 1993
A reappraisal of localization theory with reference to aphasia. Part 2: Language theories from outside neurology
R S Doody
The Journal of Nutrition, Health & Aging
|
March 23, 2010
Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design
R S Doody
Brain and Language
|
April 1, 1993
A reappraisal of localization theory with reference to aphasia. Part 1: Historical considerations
R S Doody
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 20, 1999
Clinical benefits of a new piperidine-class AChE inhibitor
R S Doody
Brain and Cognition
|
March 31, 2000
The issue of representation in brain research
R S Doody
The Journal of Prevention of Alzheimer'S Disease
|
December 21, 2017
Is Alzheimer's Disease Drug Development Broken? What Must Be Improved?
R S Doody
JAMA
|
November 14, 2000
Mortality from pneumonia and hip fractures in patients with advanced dementia
R S Doody
Alzheimer Disease and Associated Disorders
|
January 6, 2000
Therapeutic standards in Alzheimer disease
R S Doody
The Journal of Prevention of Alzheimer'S Disease
|
June 25, 2023
Viewpoint: What Is Reasonable and Necessary for People Living with AD after the FDA Approves a Treatment?
R S Doody, S Skerjanec
Page
of 5